cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Innoviva Inc
6 own
6 watching
Current Price
$12.8
$-0.16
(-1.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
893.13M
52-Week High
52-Week High
20.7056
52-Week Low
52-Week Low
11.565
Average Volume
Average Volume
1.44M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
4.7845
iconMarket Capitalization893.13M
icon52-Week High20.7056
icon52-Week Low11.565
iconAverage Volume1.44M
iconDividend Yield--
iconP/E Ratio4.7845
What does the Innoviva Inc do?
Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ...
Read More
How much money does Innoviva Inc make?
News & Events about Innoviva Inc.
Globe Newswire
3 months ago
Six abstracts selected for presentation, including three oral presentationsWALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned ...
Business Wire
5 months ago
Innoviva, Inc. (Nasdaq: INVA) (Innoviva), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of La Jolla Pharmaceutical...
Ticker Report
5 months ago
Qube Research Technologies Ltd raised its holdings in Innoviva, Inc. (NASDAQ:INVA Get Rating) by 9.3% in the first quarter, according to its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 51,432 shares of the biotechnology companys ...
Zolmax
6 months ago
StockNews.com upgraded shares of Innoviva (NASDAQ:INVA Get Rating) from a hold rating to a buy rating in a research note issued to investors on Thursday morning. INVA has been the topic of a number of other reports. The Goldman Sachs Group began coverage on shares of Innoviva in a report on ...
Globe Newswire
6 months ago
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of La Jolla Pharmaceutical Company (NASDAQ: LJPC) (La Jolla) breached their fiduciary duties or violated ...
Frequently Asked Questions
Frequently Asked Questions
What is Innoviva Inc share price today?
plus_minus_icon
Can Indians buy Innoviva Inc shares?
plus_minus_icon
How can I buy Innoviva Inc shares from India?
plus_minus_icon
Can Fractional shares of Innoviva Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Innoviva Inc stocks?
plus_minus_icon
What is today’s traded volume of Innoviva Inc?
plus_minus_icon
What is today’s market capitalisation of Innoviva Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Innoviva Inc?
plus_minus_icon
What percentage is Innoviva Inc down from its 52-Week High?
plus_minus_icon
What percentage is Innoviva Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$12.8
$-0.16
(-1.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00